An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.
Two new grants from the Leukemia & Lymphoma Society will support Weill Cornell Medicine’s pathbreaking research on the origins of lymphomas and on treatments that exploit these cancers’ biological vulnerabilities.
Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer, a new study has found.
New York Lt. Gov. Antonio Delgado engaged with students and faculty on topics ranging from biological engineering to nutrition to 4-H programs during his first tour of the Ithaca campus on Feb. 2.
The $3.5 million grant will go toward the improvement of screening and preventive treatment of cervical cancer for women living with HIV in low-resource countries.
A new Weill Cornell Medicine study solves a 50-year mystery and suggests that faulty mRNA modification may underlie some autoimmune and inflammatory disorders.
Twelve Cornell and Weill Cornell Medicine faculty members – six of whom are also Cornell alumni – have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.
A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.
